Cluster 1: Salud
- Inicio
- |
- Subvenciones y créditos
- |
- Cluster 1: Salud
El pilar I es en donde se engloban los proyectos más competitivos, los clásicos proyectos colaborativos de anteriores Programas Marcos y que agrupan a investigadores, empresas, centros de investigación y universidades
Actuaciones subvencionables
- Medicina personalizada.
- Afecciones del medioambiente en la salud y como nosotros afectamos al medioambiente.
- Abordar el Plan de Salud Europeo “One Health” en contra de la resistencia microbiana.
- Enfermedades raras.
Name | Opening date | Next deadline | Deadline model | Link |
Mission Ocean and Waters and Mission A Soil Deal for Europe – Joint demonstration of approaches and solutions to address nutrient pollution in the landscape-river-sea system in the Mediterranean sea basin | 17 January 2023 | 20 September 2023 | single-stage | |
Maintaining access to regular health and care services in case of cross-border emergencies | 12 January 2023 | 13 April 2023 | single-stage | |
Pandemic preparedness and response: Sustaining established coordination mechanisms for European adaptive platform trials and/or for cohort networks | 12 January 2023 | 13 April 2023 | single-stage | |
Novel approaches for palliative and end-of-life care for non-cancer patients | 12 January 2023 | 13 April 2023 | single-stage | |
Resilience and mental wellbeing of the health and care workforce | 12 January 2023 | 13 April 2023 | single-stage | |
Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases – GACD) | 12 January 2023 | 13 April 2023 | single-stage | |
Pandemic preparedness and response: Understanding vaccine induced-immunity | 12 January 2023 | 13 April 2023 | single-stage | |
European Partnership on Rare Diseases | 12 January 2023 | 19 September 2023 | single-stage | |
Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties | 12 January 2023 | 13 April 2023 | single-stage | |
Development and harmonisation of methodologies for assessing digital health technologies in Europe | 12 January 2023 | 13 April 2023 | single-stage | |
Towards structuring brain health research in Europe | 12 January 2023 | 13 April 2023 | single-stage | |
Evidence-based interventions for promotion of mental and physical health in changing working environments (post-pandemic workplaces) | 12 January 2023 | 13 April 2023 | single-stage | |
Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs) | 12 January 2023 | 13 April 2023 | single-stage | |
Better integration and use of health-related real-world and research data, including genomics, for improved clinical outcomes | 12 January 2023 | 13 April 2023 | single-stage | |
Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery | 12 January 2023 | 13 April 2023 | single-stage | |
Developing a Data Quality and Utility Label for the European Health Data Space | 12 January 2023 | 13 April 2023 | single-stage | |
Environmentally sustainable and climate neutral health and care systems | 12 January 2023 | 13 April 2023 | single-stage | |
European Partnership on Personalised Medicine | 12 January 2023 | 13 April 2023 | single-stage | |
Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential | 12 January 2023 | 13 April 2023 | single-stage | |
Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential | 12 January 2023 | 13 April 2023 | single-stage | |
Planetary health: understanding the links between environmental degradation and health impacts | 12 January 2023 | 13 April 2023 | single-stage | |
Expanding the European Electronic Health Record exchange Format to improve interoperability within the European Health Data Space | 12 January 2023 | 13 April 2023 | single-stage | |
The Silver Deal – Person-centred health and care in European regions | 12 January 2023 | 13 April 2023 | single-stage | |
Pragmatic clinical trials on minimally invasive diagnostics | 12 January 2023 | 13 April 2023 | single-stage | |
Mapping the hurdles for the clinical applications of Advanced Therapy Medicinal Products (ATMPs) | 12 January 2023 | 13 April 2023 | single-stage | |
Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management | 12 January 2023 | 13 April 2023 | single-stage | |
Supporting the uptake of innovative Health Technology Assessment (HTA) methodology and advancing HTA expertise across EU | 12 January 2023 | 13 April 2023 | single-stage | |
Relationship between infections and non-communicable diseases | 12 January 2023 | 13 April 2023 | single-stage | |
Global coordination of exposome research | 12 January 2023 | 13 April 2023 | single-stage | |
Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines | 12 January 2023 | 13 April 2023 | single-stage | |
Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients. | 12 January 2023 | 12 April 2023 | single-stage | |
Enhance primary cancer prevention through sustainable behavioural change | 12 January 2023 | 12 April 2023 | single-stage | |
Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats | 12 January 2023 | 13 April 2023 | single-stage | |
Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions | 12 January 2023 | 12 April 2023 | single-stage | |
Testing and demonstrating transformative solutions to build resilience towards health risks caused by the effects of climate change | 10 January 2023 | 20 September 2023 | single-stage | |
Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need | 13 December 2022 | 15 March 2023 | single-stage | |
Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases | 13 December 2022 | 13 April 2023 | single-stage | |
Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences | 13 December 2022 | 15 March 2023 | single-stage | |
Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiency | 13 December 2022 | 15 March 2023 | single-stage | |
Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation | 13 December 2022 | 15 March 2023 | single-stage |
Ámbito: Europa
Presupuesto: 8.246 M€
Organismo: Comisión europea
Naturaleza de proyecto: I+D+i
BENEFICIARIO
Cualquier tipo de organización puede solicitar la financiación de Horizon Europe siempre que tenga la capacidad operativa y financiera para llevar a cabo las tareas que propone.
TIPO Y CUANTÍA DE LA FINANCIACIÓN
Variables
GASTOS FINANCIABLES
Costes directo e indirectos relacionados con el ámbito del programa.